Tetsuya Terasaki
Division of Membrane Transport and Drug Targeting
Graduate School of Pharmaceutical Sciences
Tohoku University
Aoba, Aramaki
Japan
Name/email consistency: high
- 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. Ito, S., Ohtsuki, S., Nezu, Y., Koitabashi, Y., Murata, S., Terasaki, T. Fluids. Barriers. CNS (2011)
- Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Tamaki, C., Ohtsuki, S., Terasaki, T. Mol. Pharmacol. (2007)
- Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. Terasaki, T., Ohtsuki, S. NeuroRx (2005)
- New approaches to in vitro models of blood-brain barrier drug transport. Terasaki, T., Ohtsuki, S., Hori, S., Takanaga, H., Nakashima, E., Hosoya, K. Drug Discov. Today (2003)
- The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier. Tetsuka, K., Takanaga, H., Ohtsuki, S., Hosoya, K., Terasaki, T. J. Neurochem. (2003)
- Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Terasaki, T., Hosoya, K. Biol. Pharm. Bull. (2001)